Translocator Protein and Neurodegeneration: Insights from Alzheimer's Disease

Overview

Journal Neural Regen Res

Date 2024 Jul 11

PMID 38989945

Authors

Arpit Kumar Pradhan

Rainer Rupprecht

Gerhard Rammes

Affiliations

Soon will be listed here.

References

Fernandez A, Llacuna L, Fernandez-Checa J, Colell A . Mitochondrial cholesterol loading exacerbates amyloid beta peptide-induced inflammation and neurotoxicity. J Neurosci. 2009; 29(20):6394-405. PMC: 2740839. DOI: 10.1523/JNEUROSCI.4909-08.2009. View

Li H, Yao Z, Degenhardt B, Teper G, Papadopoulos V . Cholesterol binding at the cholesterol recognition/ interaction amino acid consensus (CRAC) of the peripheral-type benzodiazepine receptor and inhibition of steroidogenesis by an HIV TAT-CRAC peptide. Proc Natl Acad Sci U S A. 2001; 98(3):1267-72. PMC: 14743. DOI: 10.1073/pnas.98.3.1267. View

Dharshini S, Taguchi Y, Gromiha M . Investigating the energy crisis in Alzheimer disease using transcriptome study. Sci Rep. 2019; 9(1):18509. PMC: 6898285. DOI: 10.1038/s41598-019-54782-y. View

Gokce M, Velioglu H, Bektay M, Guler E . Evaluating the Clinical Significance of Diazepam Binding Inhibitor in Alzheimer's Disease: A Comparison with Inflammatory, Oxidative, and Neurodegenerative Biomarkers. Gerontology. 2023; 69(9):1104-1112. DOI: 10.1159/000531849. View

Notter T, Schalbetter S, Clifton N, Mattei D, Richetto J, Thomas K . Neuronal activity increases translocator protein (TSPO) levels. Mol Psychiatry. 2020; 26(6):2025-2037. PMC: 8440208. DOI: 10.1038/s41380-020-0745-1. View

Nutma E, Ceyzeriat K, Amor S, Tsartsalis S, Millet P, Owen D . Cellular sources of TSPO expression in healthy and diseased brain. Eur J Nucl Med Mol Imaging. 2021; 49(1):146-163. PMC: 8712293. DOI: 10.1007/s00259-020-05166-2. View

Rupprecht R, Wetzel C, Dorostkar M, Herms J, Albert N, Schwarzbach J . Translocator protein (18kDa) TSPO: a new diagnostic or therapeutic target for stress-related disorders?. Mol Psychiatry. 2022; 27(7):2918-2926. DOI: 10.1038/s41380-022-01561-3. View

Rupprecht R, Pradhan A, Kufner M, Brunner L, Nothdurfter C, Wein S . Neurosteroids and translocator protein 18 kDa (TSPO) in depression: implications for synaptic plasticity, cognition, and treatment options. Eur Arch Psychiatry Clin Neurosci. 2022; 273(7):1477-1487. DOI: 10.1007/s00406-022-01532-3. View

Pradhan A, Neumuller T, Klug C, Fuchs S, Schlegel M, Ballmann M . Chronic administration of XBD173 ameliorates cognitive deficits and neuropathology via 18 kDa translocator protein (TSPO) in a mouse model of Alzheimer's disease. Transl Psychiatry. 2023; 13(1):332. PMC: 10611770. DOI: 10.1038/s41398-023-02630-z. View

10.

Conti E, Grana D, Angiulli F, Karantzoulis A, Villa C, Combi R . TSPO Modulates Oligomeric Amyloid-β-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease. J Alzheimers Dis. 2023; 95(2):549-559. DOI: 10.3233/JAD-230239. View

11.

Tu L, Morohaku K, Manna P, Pelton S, Butler W, Stocco D . Peripheral benzodiazepine receptor/translocator protein global knock-out mice are viable with no effects on steroid hormone biosynthesis. J Biol Chem. 2014; 289(40):27444-54. PMC: 4183784. DOI: 10.1074/jbc.M114.578286. View

12.

Fairley L, Lai K, Wong J, Chong W, Vincent A, DAgostino G . Mitochondrial control of microglial phagocytosis by the translocator protein and hexokinase 2 in Alzheimer's disease. Proc Natl Acad Sci U S A. 2023; 120(8):e2209177120. PMC: 9974442. DOI: 10.1073/pnas.2209177120. View

13.

LaFerla F . Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat Rev Neurosci. 2002; 3(11):862-72. DOI: 10.1038/nrn960. View

14.

Yang J, Yang H, Liu Y, Li X, Qin L, Lou H . Astrocytes contribute to synapse elimination via type 2 inositol 1,4,5-trisphosphate receptor-dependent release of ATP. Elife. 2016; 5:e15043. PMC: 4829431. DOI: 10.7554/eLife.15043. View

15.

Rupprecht R, Rammes G, Eser D, Baghai T, Schule C, Nothdurfter C . Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects. Science. 2009; 325(5939):490-3. DOI: 10.1126/science.1175055. View

16.

Danysz W, Parsons C . Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connections. Br J Pharmacol. 2012; 167(2):324-52. PMC: 3481041. DOI: 10.1111/j.1476-5381.2012.02057.x. View